SE0102808D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0102808D0
SE0102808D0 SE0102808A SE0102808A SE0102808D0 SE 0102808 D0 SE0102808 D0 SE 0102808D0 SE 0102808 A SE0102808 A SE 0102808A SE 0102808 A SE0102808 A SE 0102808A SE 0102808 D0 SE0102808 D0 SE 0102808D0
Authority
SE
Sweden
Prior art keywords
new compounds
whichinhibit
usedin
exogenously
prevention
Prior art date
Application number
SE0102808A
Other languages
English (en)
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0102808A priority Critical patent/SE0102808D0/sv
Publication of SE0102808D0 publication Critical patent/SE0102808D0/sv
Priority to ARP020103019A priority patent/AR035465A1/es
Priority to MXPA04001402A priority patent/MXPA04001402A/es
Priority to PL02367971A priority patent/PL367971A1/xx
Priority to JP2003523243A priority patent/JP2005501870A/ja
Priority to NZ531110A priority patent/NZ531110A/en
Priority to CNB028160177A priority patent/CN100343252C/zh
Priority to RU2004103628/04A priority patent/RU2294935C2/ru
Priority to KR10-2004-7002466A priority patent/KR20040036723A/ko
Priority to CA002456350A priority patent/CA2456350A1/en
Priority to IL16014302A priority patent/IL160143A0/xx
Priority to BR0211846-7A priority patent/BR0211846A/pt
Priority to PCT/SE2002/001489 priority patent/WO2003018582A1/en
Priority to US10/487,149 priority patent/US20040220209A1/en
Priority to HU0401350A priority patent/HUP0401350A3/hu
Priority to EP02759036A priority patent/EP1421083A1/en
Priority to ZA200401114A priority patent/ZA200401114B/en
Priority to IS7159A priority patent/IS7159A/is
Priority to NO20040760A priority patent/NO20040760L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0102808A 2001-08-22 2001-08-22 New compounds SE0102808D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds
ARP020103019A AR035465A1 (es) 2001-08-22 2002-08-09 Compuestos de imidazopiridina, procesos para su preparacion,formulacion farmaceutica, usos de estos compuestos para la fabricacion de medicamentos e intermediarios
EP02759036A EP1421083A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
KR10-2004-7002466A KR20040036723A (ko) 2001-08-22 2002-08-21 치료 효과를 갖는 신규 이미다조피리딘 화합물
BR0211846-7A BR0211846A (pt) 2001-08-22 2002-08-21 Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para inibir a secreção de ácido gástrico, para tratar doenças gastrintestinais inflamatórias, e para tratar ou profilaxia de condições envolvendo infecção por helicobacter pylori de mucosa gástrica humana
JP2003523243A JP2005501870A (ja) 2001-08-22 2002-08-21 治療効果を有する新規なイミダゾピリジン化合物
NZ531110A NZ531110A (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
CNB028160177A CN100343252C (zh) 2001-08-22 2002-08-21 具有治疗作用的新咪唑并吡啶化合物
RU2004103628/04A RU2294935C2 (ru) 2001-08-22 2002-08-21 Имидазопиридиновые производные для применения в терапии в качестве лекарственного средства, ингибирующего протонный насос, и промежуточные соединения для их получения
MXPA04001402A MXPA04001402A (es) 2001-08-22 2002-08-21 Compuestos de imidazopiridina novedosos con efecto terapeutico.
CA002456350A CA2456350A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
IL16014302A IL160143A0 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
PL02367971A PL367971A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
PCT/SE2002/001489 WO2003018582A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
US10/487,149 US20040220209A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect
HU0401350A HUP0401350A3 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect, process for their preparation and pharmaceutical compositions containing them
ZA200401114A ZA200401114B (en) 2001-08-22 2004-02-11 Novel imidazoipyridine compounds with therapeutic effect.
IS7159A IS7159A (is) 2001-08-22 2004-02-20 Ný imídasópýridínefnasambönd sem hafa meðferðarfræðileg áhrif
NO20040760A NO20040760L (no) 2001-08-22 2004-02-20 Nye imidazopyridinforbindelser med terapeutisk virkning

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds

Publications (1)

Publication Number Publication Date
SE0102808D0 true SE0102808D0 (sv) 2001-08-22

Family

ID=20285105

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds

Country Status (19)

Country Link
US (1) US20040220209A1 (sv)
EP (1) EP1421083A1 (sv)
JP (1) JP2005501870A (sv)
KR (1) KR20040036723A (sv)
CN (1) CN100343252C (sv)
AR (1) AR035465A1 (sv)
BR (1) BR0211846A (sv)
CA (1) CA2456350A1 (sv)
HU (1) HUP0401350A3 (sv)
IL (1) IL160143A0 (sv)
IS (1) IS7159A (sv)
MX (1) MXPA04001402A (sv)
NO (1) NO20040760L (sv)
NZ (1) NZ531110A (sv)
PL (1) PL367971A1 (sv)
RU (1) RU2294935C2 (sv)
SE (1) SE0102808D0 (sv)
WO (1) WO2003018582A1 (sv)
ZA (1) ZA200401114B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
DE602005009257D1 (de) * 2004-12-17 2008-10-02 Pfizer Chroman-derivate als säurepumpenantagonisten
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
CA2645007A1 (en) * 2006-03-17 2007-09-27 Raqualia Pharma Inc. Chromane derivatives
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
KR200449743Y1 (ko) * 2008-03-11 2010-08-05 주식회사 보루네오가구 파티션용 상부 스크린의 고정구조
FI20086158A0 (sv) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidazopyridinederivater
BRPI1013288A2 (pt) 2009-07-09 2016-03-29 Raqualia Pharma Inc uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto
TWI402268B (zh) * 2009-09-24 2013-07-21 Hoffmann La Roche 新穎之咪唑并吡啶衍生物
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
PL3381917T3 (pl) * 2013-01-31 2021-12-27 Bellus Health Cough Inc. Związki imidazopirydynowe i i ch zastosowania
CA2909477A1 (en) * 2013-04-30 2014-11-06 F. Hoffmann-La Roche Ag Pd-catalyzed coupling of pyrazole amides
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
CN1543464A (zh) 2004-11-03
IS7159A (is) 2004-02-20
RU2294935C2 (ru) 2007-03-10
RU2004103628A (ru) 2005-06-27
IL160143A0 (en) 2004-06-20
KR20040036723A (ko) 2004-04-30
US20040220209A1 (en) 2004-11-04
AR035465A1 (es) 2004-05-26
CA2456350A1 (en) 2003-03-06
JP2005501870A (ja) 2005-01-20
BR0211846A (pt) 2004-09-08
NZ531110A (en) 2005-10-28
CN100343252C (zh) 2007-10-17
NO20040760L (no) 2004-02-20
PL367971A1 (en) 2005-03-07
HUP0401350A3 (en) 2009-03-02
EP1421083A1 (en) 2004-05-26
HUP0401350A2 (hu) 2004-12-28
MXPA04001402A (es) 2004-05-27
WO2003018582A1 (en) 2003-03-06
ZA200401114B (en) 2005-06-22

Similar Documents

Publication Publication Date Title
SE9801526D0 (sv) New compounds
SE9704404D0 (sv) New compounds
SE9700661D0 (sv) New compounds
SE0102808D0 (sv) New compounds
SE9802794D0 (sv) New compounds
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
SE9802793D0 (sv) New compounds
CY1114038T1 (el) Παραγωγα ιμιδαζοπυριδινης τα οποια αναστελλουν την εκκριση γαστρικου οξεος
EA200601589A1 (ru) Производные 7h-8,9-дигидропирано-(2,3-c)имидазо(1,2a)пиридина и их применение в качестве ингибиторов секреции кислоты желудочного сока
ATE311389T1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
NO20060425L (no) Ny imidazopyridinforbindelse II med terapeutisk effekt
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
AR044854A1 (es) Compuesto de imidazopiridina